Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Prenol Lipids [PR] (W) --> Isoprenoids [PR01]--> C15 isoprenoids (sesquiterpenes) [PR0103]--> Cyclofarnesane sesquiterpenoids [PR010305]
LM_IDCommon NameSystematic NameFormulaMass
LMPR0103050001(S)-(+)-Abscisic acid (W)-C15H20O4264.1362
LMPR0103050002(-)-abscisic aldehyde(2Z,4E)-5-[(1R)-1-hydroxy-2,6,6-
trimethyl-4-oxocyclohex-2-en-1-yl]-3-
methylpenta-2,4-dienal
C15H20O3248.1412
LMPR0103050003Latia luciferin(1E)-2-methyl-4-(2,6,6-
trimethylcyclohex-1-en-1-yl)but-1-enyl
formate
C15H24O2236.1776
LMPR0103050004abscisic aldehyde(2Z,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-
oxocyclohex-2-en-1-yl)-3-methylpenta-2,
4-dienal
C15H20O3248.1412
LMPR0103050005dihydrophaseic acid(2Z,4E)-5-[(1R,3S,5R,8S)-3,8-dihydroxy-
1,5-dimethyl-6-oxabicyclo[3.2.1]oct-8-
yl]-3-methylpenta-2,4-dienoic acid
C15H22O5282.1467
LMPR0103050006dihydrophaseic acid 4-O-β-D-glucoside(2Z,4E)-5-[(1R,3S,5R,8S)-3-(β-D-
glucopyranosyloxy)-8-hydroxy-1,5-
dimethyl-6-oxabicyclo[3.2.1]oct-8-yl]-
3-methylpenta-2,4-dienoic acid
C21H32O10444.1996
LMPR0103050007epi-dihydrophaseic acid(2Z,4E)-5-[(1R,3R,5R,8S)-3,8-dihydroxy-
1,5-dimethyl-6-oxabicyclo[3.2.1]oct-8-
yl]-3-methylpenta-2,4-dienoic acid
C15H22O5282.1467
LMPR0103050008(-)-abscisic acid (W)(2Z,4E)-5-[(1R)-1-hydroxy-2,6,6-
trimethyl-4-oxocyclohex-2-en-1-yl]-3-
methylpenta-2,4-dienoic acid
C15H20O4264.1362
LMPR0103050009(6S)-dehydrovomifoliol(4S)-4-hydroxy-3,5,5-trimethyl-4-[(1E)-
3-oxobut-1-en-1-yl]cyclohex-2-en-1-one
C13H18O3222.1256
LMPR0103050010(+)-8'-hydroxyabscisic acid(2Z,4E)-5-[(1R,6R)-1-hydroxy-6-
(hydroxymethyl)-2,6-dimethyl-4-
oxocyclohex-2-en-1-yl]-3-methylpenta-2,
4-dienoic acid
C15H20O5280.1311
LMPR0103050011(+)-abscisic acid β-D-glucopyranosyl
ester
1-O-{(2Z,4E)-5-[(1S)-1-hydroxy-2,6,6-
trimethyl-4-oxocyclohex-2-en-1-yl]-3-
methylpenta-2,4-dienoyl}-β-D-
glucopyranose
C21H30O9426.1890
LMPR0103050012(R)-2-trans-abscisic acid(2E,4E)-5-[(1R)-1-hydroxy-2,6,6-
trimethyl-4-oxocyclohex-2-en-1-yl]-3-
methylpenta-2,4-dienoic acid
C15H20O4264.1362
LMPR01030500131'-deoxyabscisic acid3-methyl-5-(2,6,6-trimethyl-4-
oxocyclohex-2-en-1-yl)-2Z,4E-
pentadienoic acid
C15H20O3248.1412
LMPR01030500147'-hydroxyabscisic acid(2Z,4E)-5-[1-hydroxy-2-(hydroxymethyl)-
6,6-dimethyl-4-oxocyclohex-2-en-1-yl]-
3-methylpenta-2,4-dienoic acid
C15H20O5280.1311
 

logo LIPID MAPS is funded by a Wellcome Trust.